Rep. Weber Sends Letter to FDA's Division of Rare Disease and Medical Genetics
April 20, 2023
April 20, 2023
WASHINGTON, April 20 -- Rep. Randy Weber, R-Texas, issued the following news release and letter:
U.S. Reps. Randy Weber (TX-14), Brian Babin (TX-36), and Dan Crenshaw (TX-02) sent a letter to the Food and Drug Administration's (FDA) Division of Rare Disease and Medical Genetics (DRDMG) to urge the FDA to reconsider clinical trial designs within the population of certain fatal heterogeneous degenerative diseases so that patients do not have to choose between medication that is s . . .
U.S. Reps. Randy Weber (TX-14), Brian Babin (TX-36), and Dan Crenshaw (TX-02) sent a letter to the Food and Drug Administration's (FDA) Division of Rare Disease and Medical Genetics (DRDMG) to urge the FDA to reconsider clinical trial designs within the population of certain fatal heterogeneous degenerative diseases so that patients do not have to choose between medication that is s . . .